Pharmacodynamic assessment in whole blood for the BET bromodomain inhibitor CPI-0610 of target engagement in patients with progressive lymphoma Meeting Abstract


Authors: Mertz, J. A.; Blum, K. A.; Younes, A.; Abramson, J. S.; Maris, M. B.; Flinn, I. W.; Goy, A.; Borger, D. R.; Cooper, M. R.; Sims, R. J.
Abstract Title: Pharmacodynamic assessment in whole blood for the BET bromodomain inhibitor CPI-0610 of target engagement in patients with progressive lymphoma
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468819501465
DOI: 10.1158/1538-7445.Am2018-3674
PROVIDER: wos
Notes: Meeting Abstract: 3674 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anas Younes
    319 Younes